- $6.23bn
- $6.03bn
- $383.48m
- 76
- 19
- 72
- 58
Annual balance sheet for Glaukos, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Cash and Equivalents | |||||
| Short Term Investments | |||||
| Cash and Short Term Investments | 404 | 414 | 353 | 295 | 319 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 36.1 | 33.4 | 36.1 | 39.9 | 60.7 |
| Total Inventory | |||||
| Prepaid Expenses | |||||
| Total Current Assets | 469 | 486 | 444 | 395 | 450 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 95.5 | 146 | 167 | 175 | 170 |
| Net Goodwill | |||||
| Net Intangible Assets | |||||
| Other Long Term Assets | |||||
| Total Assets | 1,006 | 1,050 | 1,002 | 940 | 975 |
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Total Current Liabilities | 49.7 | 63.4 | 72.4 | 74 | 75.1 |
| Long Term Debt | |||||
| Capital Lease Obligations | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Deferred Income Tax | |||||
| Total Other Liabilities | |||||
| Total Liabilities | 338 | 463 | 472 | 479 | 208 |
| Redeemable Preferred Stock | |||||
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Treasury Stock | |||||
| Other Equity | |||||
| Total Equity | 667 | 587 | 530 | 462 | 767 |
| Total Liabilities & Shareholders' Equity | 1,006 | 1,050 | 1,002 | 940 | 975 |
| Total Common Shares Outstanding |